European Leukemia Trial Registry
Trial: MDS ALGATG

More Details
Short Title MDS ALGATG
Trialgroup Deutsche MDS
Type of Trial randomized, prospective, open-label
Disease Myelodysplastic Syndrome(MDS) All subtypes
Age >= 18 years
Status Closed
Start of Recruitment 01.01.2003
Leader Ganser, Prof. Dr. med., Arnold
Contactperson

Study Physician
Verbeek, PD Dr. med., Walter
Email: Verbeek.Walter@mh-hannover.de

Centre of Trial Medizinische Hochschule Hannover (MHH)
Shortprotocol Shortprotocol
Diagnostics

Floureszenz-In-Situ-Hybridisierung (FISH)
Labor für Leukämieforschung der Medizinischen Hochschule Hannover

created 19.09.2006 Anja Hellenbrecht
changed 15.11.2011 Johannes Kraus
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org